Skip to Content
Merck
  • Essential differences in oncogene involvement between primary nodal and extranodal large cell lymphoma.

Essential differences in oncogene involvement between primary nodal and extranodal large cell lymphoma.

Blood (1991-11-15)
S Raghoebier, M H Kramer, J H van Krieken, D de Jong, J Limpens, J C Kluin-Nelemans, G J van Ommen, P M Kluin
ABSTRACT

Large cell lymphomas (LCLs) are heterogeneous in morphology, clinical presentation, and behavior. We studied 52 de novo LCLs of B-cell type for rearrangements of the bcl-2 and c-myc oncogenes by Southern blot analysis and related these data to the primary site of presentation, stage, and cytomorphology. Thirteen tumors had comigrating rearrangements of JH and bcl-2, indicative of a t(14;18). Far more primary nodal lymphomas than extranodal lymphomas carried a t(14;18) (40% v less than 5%). Additionally, almost all lymphomas with a t(14;18) versus 41% of the tumors without a bcl-2 rearrangement presented with lymphadenopathy. c-myc rearrangements were seen in 35% of the extranodal lymphomas and 5% of the nodal lymphomas. No differences were observed in bone marrow involvement and staging according to Ann Arbor. bcl-2 rearrangements were found in 50% of the LCLs with cleaved nuclei, whereas c-myc rearrangements were relatively frequent (25%) in the noncleaved subtype. Our data support the hypothesis that primary nodal and extranodal lymphomas have a different genetic origin.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
CD23 (EP75) Rabbit Monoclonal Primary Antibody
Sigma-Aldrich
CD23 (MRQ-57) Mouse Monoclonal Antibody
Sigma-Aldrich
CD23 (SP23) Rabbit Monoclonal Antibody